Related references
Note: Only part of the references are listed.Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis
Katherine E. Lintner et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis
Clara Malattia et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
Dragana Lazarevic et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Clinical features and disease course of patients with juvenile dermatomyositis
Peter J. Gowdie et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
Developments in the Classification and Treatment of the Juvenile Idiopathic Inflammatory Myopathies
Lisa G. Rider et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2013)
Consensus treatments for moderate Juvenile Dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference
Adam M. Huber et al.
ARTHRITIS CARE & RESEARCH (2012)
Serial magnetic resonance imaging in juvenile dermatomyositis
David R. Keim et al.
ARTHRITIS AND RHEUMATISM (2010)
An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)
V. E. Brown et al.
RHEUMATOLOGY (2006)
National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary -: Clinical characteristics and disease course of 44 patients with juvenile dermatomyositis
T. Constantin et al.
AUTOIMMUNITY (2006)
The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids
AV Ramanan et al.
ARTHRITIS AND RHEUMATISM (2005)
Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis
SM Maillard et al.
RHEUMATOLOGY (2004)
Share Paper
